*****333.7335 THIS SECTION DOES NOT APPLY AFTER NOVEMBER 1, 1987: See (7) of 333.7336 *****
Sec. 7335.
(1) There shall be established in the department a marihuana controlled substances therapeutic research program. The administration of the program shall conform with pertinent rules and regulations of the drug enforcement agency, food and drug administration, and the national institute on drug abuse relative to the use of marihuana for therapeutic purposes.
(2) Participation in the marihuana controlled substances therapeutic research program shall be limited to cancer chemotherapy patients and glaucoma patients who are certified to the department by a physician as being involved in a life-threatening or sense-threatening situation, and who is not responding to conventional medical treatment or when conventional medical treatment administered has proven to be effective, but the patient has incurred severe side effects. A physician who certifies a patient for participation in the marihuana controlled substances research program shall be a physician as defined in section 17001 or 17501 and shall be certified by the department.
(3) Notwithstanding subsection (2), the department may include any other disease groups for participation in the marihuana controlled substances therapeutic research program for which the department has obtained an investigational new drug permit from the food and drug administration.
(4) If federal sources do not provide supplies of marihuana adequate for patient use pursuant to this section and section 7336, the department shall approve the use of marihuana obtained from law enforcement agencies in this state, until adequate marihuana is received from federal sources. Any marihuana obtained from law enforcement agencies in this state shall be tested for purity and dosage by the department or a laboratory designated by the department. Any marihuana distributed pursuant to this section and section 7336 shall meet standards of purity and dosage as determined by the department.
History: Add. 1982, Act 352, Imd. Eff. Dec. 21, 1982
Compiler's Notes: Former MCL 333.7335, pertaining to marihuana controlled substances therapeutic research program, expired November 1, 1982, pursuant to Act 125 of 1979.
Popular Name: Act 368